CUIMC Research Pharmacy — New York, New York

CUIMC Research Pharmacy is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

CUIMC Research Pharmacy has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Healthy.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CUIMC Research Pharmacy?

CUIMC Research Pharmacy has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CUIMC Research Pharmacy conducted?

CUIMC Research Pharmacy has 3 clinical trials on record, with 2 currently active. Their work covers Myelodysplastic Syndrome, Acute Myeloid Leukemia, Healthy.

Is CUIMC Research Pharmacy accredited by Crixeo Health?

CUIMC Research Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CUIMC Research Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.